Candriam SCA’s Dynavax Technologies DVAX Stock Holding History

Candriam SCA’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-69,000	Closed	-$1.37M	–	803
2018 Q1	$1.37M	Sell	69,000 -11,000	-14%	-$190K	0.02%	540
2017 Q4	$1.5M	Sell	80,000 -163,000	-67%	-$3.27M	0.03%	508
2017 Q3	$5.22M	Sell	243,000 -282,000	-54%	-$4.46M	0.09%	256
2017 Q2	$5.07M	Buy	+525,000	New	+$3.41M	0.1%	258
2016 Q3	–	Sell	-71,500	Closed	-$1.04M	–	664
2016 Q2	$1.04M	Hold	71,500	–	–	0.03%	427
2016 Q1	$1.37M	Buy	+71,500	New	+$1.44M	0.03%	380
2015 Q4	–	Sell	-128,800	Closed	-$3.16M	–	600
2015 Q3	$3.16M	Buy	128,800 +76,800	+148%	+$2.17M	0.08%	270
2015 Q2	$1.22M	Buy	+52,000	New	+$1.13M	0.03%	420

Other funds holding DVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Candriam SCA's DVAX Position: Q2 2018 in Review

Candriam SCA sold out of Dynavax Technologies (DVAX) in Q2 2018, closing a stake of 69,000 shares — an estimated $1.37M sold.

Candriam SCA first reported a position in DVAX in Q2 2015 and held it in 8 quarters. The position peaked at $5.22M in Q3 2017. 155 funds tracked by Wall St. Rank hold DVAX as of Q2 2018.

Candriam SCA reported no remaining Dynavax Technologies position as of Q2 2018 after selling out during the quarter.
Candriam SCA sold 69,000 Dynavax Technologies shares in Q2 2018, an estimated $1.37M.
Candriam SCA first reported a position in Dynavax Technologies in Q2 2015 and held it in 8 quarters.
Candriam SCA's Dynavax Technologies position peaked at $5.22M in Q3 2017.
155 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2018.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.